Ionis制药 IONS 深 沪
已收盘 10-31 16:00:00 美东时间
74.30
+0.130
+0.18%
华盛通- 最 高75.4899
- 今 开74.50
- 成交量 239.56万股
- 最 低 74.02
- 昨 收 74.17
- 总市值 118.14亿
- 52周最高 75.4899
- 市盈率 静 --
- 换手率 1.51%
- 52周最低 23.95
- 委 比 96.31%
- 总股本 1.59亿
- 历史最高 86.582
- 量 比 1.12
- 振 幅 1.98%
- 历史最低 6.25
- 每 手 1
- 风险率 12.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Preview: Exact Sciences
Exact Sciences (NASDAQ:EXAS) is gearing up to announce its quarterly earnings o...
10-31 23:01
美股大行评级 | 最高350美元！16家大行上调谷歌目标价！Meta遭12家大行下调目标价；潜在涨幅1456.29%！NRX Pharmaceuticals获Ascendiant Capital升目标价至47美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从46美元升至47美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从27美元升至31美元
10-31 10:25
GigaMedia Announces Third-Quarter 2025 Financial Results
TAIPEI, Oct. 30, 2025 /PRNewswire/ -- GigaMedia Limited (NASDAQ: GIGM) today announced its third-quarter 2025 unaudited financial results. Comments from Management In the third quarter of 20...
10-30 21:00
Needham Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $90
Needham analyst Joseph Stringer maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and raises the price target from $78 to $90.
10-30 18:19
Humacyte Announces Publication of New Data Comparing Symvess™ to Autologous Vein in Extremity Arterial Trauma
Humacyte announced the publication of a study comparing Symvess to autologous vein in treating extremity arterial trauma. Results showed similar short-term outcomes in patency, limb salvage, and infection rates. Symvess achieved comparable primary patency (86.6% vs. 91.8%), secondary patency (91.0% vs. 97.7%), amputation rate (7.5% vs. 8.2%), and death rate (4.5% vs. 4.5%). While autologous vein is the current gold standard, Symvess offers a viab...
10-30 12:00
康菲中国总裁胡凯诚荣获中国政府友谊奖
北京2025年10月30日 /美通社/ -- 康菲石油中国有限公司（"康菲中国"）总裁胡凯诚（Markel Hübinette）先生荣获2025年度中国政府友谊...
10-30 11:12
PIZZA HUT CELEBRATES "HALLO-WINGS" BY SCARING THE COMPETITION
Pizza Hut Haunts Wingstop by Deploying a Fleet of Out-of-Home Locations at Wingstop Headquarters and Stores Designed to Remind the World Pizza Hut is an Authority in Both Pizza and Wings PLA...
10-30 02:54
Examining the Future: Biogen's Earnings Outlook
Biogen (NASDAQ:BIIB) is gearing up to announce its quarterly earnings on Thursd...
10-30 01:02
Earnings Scheduled For October 29, 2025
Companies Reporting Before The Bell • OppFi (NYSE:OPFI) is expected to report q...
10-29 19:11
Ionis Pharmaceuticals Raises FY2025 Sales Guidance from $825.000M-$850.000M to $875.000M-$900.000M vs $857.588M Est
Ionis Pharmaceuticals (NASDAQ:IONS) raises FY2025 sales outlook from $825.000 million-$850.000 million to $875.000 million-$900.000 million vs $857.588 million estimate.
10-29 19:03
